CC BY-NC-ND 4.0 · Endosc Int Open 2023; 11(09): E794-E799
DOI: 10.1055/a-2100-9076
Review

Early versus late endoscopic treatment of pancreatic necrotic collections: A systematic review and meta-analysis

1   Gastroenterology, Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, United States (Ringgold ID: RIN12313)
,
Muhammad Ali Khan
2   Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, United States (Ringgold ID: RIN4002)
,
Wade M. Lee-Smith
3   University Libraries, University of Toledo, Toledo, United States
,
Sachit Sharma
4   Internal Medicine, University of Toledo, Toledo, United States (Ringgold ID: RIN7923)
,
Ashu Acharya
4   Internal Medicine, University of Toledo, Toledo, United States (Ringgold ID: RIN7923)
,
Alec E Faggen
5   Gastroenterology, University of California San Francisco, San Francisco, United States (Ringgold ID: RIN8785)
,
6   Department of Medicine, Loyola Medicine/MacNeal Hospital, Berwyn, United States
,
Zahid I Tarar
7   Internal Medicine, University of Missouri School of Medicine, Columbia, United States (Ringgold ID: RIN12271)
,
Muhammad Aziz
4   Internal Medicine, University of Toledo, Toledo, United States (Ringgold ID: RIN7923)
,
Todd Baron
8   Gastroenterology & Hepatology, University of North Carolina, Chapel Hill, United States
› Author Affiliations

Abstract

Background and study aims Recently studies have compared early (<4 weeks) vs. late or standard (>4 weeks) endoscopic treatment of pancreatic necrotic collections (PNC) and have reported favorable results for early treatment. In this meta-analysis, we compared the efficacy and safety of early vs. late endoscopic treatment of PNC.

Patients and methods We reviewed several databases from inception to September 30, 2021 to identify studies that compared early with late endoscopic treatment of PNC. Our outcomes of interest were adverse events (AEs), resolution of PNC, performance of direct endoscopic necrosectomy, need for further interventions, and mean number of endoscopic necrosectomy sessions. We calculated pooled risk ratios (RRs) with 95% confidence intervals (CIs) for categorical variables and mean differences (MDs) with 95% CIs for continuous variables. Data were analyzed by random effect model. Heterogeneity was assessed by I2 statistic.

Results We included four studies with 427 patients. We found no significant difference in rates of AEs, RR (95% CI) 1.70 (range, 0.56–5.20), resolution of necrotic or fluid collections, RR (95% CI) 0.89 (range, 0.71–1.11), need for further interventions, RR (95% CI) 1.47 (range, 0.70–3.08), direct necrosectomy, RR (95% CI) 1.39 (range, 0.22–8.80), mortality, RR (95% CI) 2.37 (range, 0.26–21.72) and mean number of endoscopic necrosectomy sessions, MD (95% CI) 1.58 (range,–0.20–3.36) between groups.

Conclusions Early endoscopic treatment of PNC can be considered for indications such as infected necrosis or sterile necrosis with symptoms or complications; however, future large multicenter studies are required to further evaluate its safety.

Supporting information



Publication History

Received: 28 February 2022

Accepted after revision: 17 May 2023

Accepted Manuscript online:
25 May 2023

Article published online:
04 September 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany